|Articles|May 15, 2002
- BioPharm International-05-01-2002
- Volume 15
- Issue 5
Washington Report: Vaccine Shortages put Spotlight on Production
Author(s)Jill Wechsler
by Jill Wechsler Bioterrorism and common infections create challenges for manufacturers.
Advertisement
Articles in this issue
over 23 years ago
Info+over 23 years ago
Analytical Advances: Strategies in Clarifying Mammalian Culturesover 23 years ago
Analytical Advances: Using Image Informatics - Focusing Proteomicsover 23 years ago
The Not-So-Sure Thingover 23 years ago
Guest Editorial: Validation Bingoover 23 years ago
Travel Notes: Yes, Virginia, There is Biotech in the CommonwealthNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
GSK Advances Vaccine Delivery and Hepatitis B Treatment
3
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
4
Why AI-Native Cell Manufacturing Is the Future of Drug Discovery (Part 1)
5
